Luo Xin, McAndrews Kathleen M, Kalluri Raghu
Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.
Department of Bioengineering, Rice University, Houston, Texas 77005, United States.
ACS Nano. 2025 Feb 18;19(6):5871-5896. doi: 10.1021/acsnano.4c11630. Epub 2025 Jan 27.
Extracellular vesicles (EVs) are cell derived nanovesicles which are implicated in both physiological and pathological intercellular communication, including the initiation, progression, and metastasis of cancer. The exchange of biomolecules between stromal cells and cancer cells via EVs can provide a window to monitor cancer development in real time for better diagnostic and interventional strategies. In addition, the process of secretion and internalization of EVs by stromal and cancer cells in the tumor microenvironment (TME) can be exploited for delivering therapeutics. EVs have the potential to provide a targeted, biocompatible, and efficient delivery platform for the treatment of cancer and other diseases. Natural as well as engineered EVs as nanomedicine have immense potential for disease intervention. Here, we provide an overview of current knowledge of EVs' function in cancer progression, diagnostic and therapeutic applications for EVs in the cancer setting, as well as current EV engineering strategies.
细胞外囊泡(EVs)是源自细胞的纳米囊泡,参与生理和病理的细胞间通讯,包括癌症的起始、进展和转移。基质细胞和癌细胞之间通过细胞外囊泡进行的生物分子交换可以为实时监测癌症发展提供一个窗口,从而制定更好的诊断和干预策略。此外,肿瘤微环境(TME)中的基质细胞和癌细胞对细胞外囊泡的分泌和内化过程可用于递送治疗药物。细胞外囊泡有潜力为癌症和其他疾病的治疗提供一个靶向、生物相容且高效的递送平台。天然以及经过工程改造的细胞外囊泡作为纳米药物在疾病干预方面具有巨大潜力。在此,我们概述了目前关于细胞外囊泡在癌症进展中的功能、细胞外囊泡在癌症环境中的诊断和治疗应用的知识,以及当前的细胞外囊泡工程策略。